A new venture fund building a sustainable society through early-stage investments in the Industrial Biotech industry.
Today, Capricorn Partners announced the establishment of Capricorn Industrial Biotech Fund, a new fund as part of its Cleantech portfolio of funds. The Capricorn Industrial Biotech Fund invests in early-stage ventures that are using biotechnology solutions to meet the growing demand for products made in a sustainable way.
Industrial Biotechnology is a key technology for the transformation of society towards Net Zero Carbon and Circularity. This industry will accelerate rapidly in the next decades, driven by recent advancements in bio-engineering, Artificial Intelligence, process technology, and a growing regulatory push for low carbon industry. Industrial Biotechnology will provide sustainable alternatives for food & feed ingredients, chemicals and intermediates, advanced materials and energy.
Industrial Biotechnology is in a technology lifecycle phase that is favorable for early-stage venture investing. Many promising technologies are being developed at universities and technology institutes, with a particularly strong presence in the Benelux and other countries in North-West Europe. Capricorn Industrial Biotech Fund invests in early-stage ventures in this industry, and assists them with their growth.
For further reading please go to Capricorn’s website.
Capricorn Partners
Lei 19, 3000 Leuven, Belgium
T: +32 16 28 41 00
capricorn@capricorn.be
